Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (August 12, 2021) -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15th. Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:30 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast replay will be available approximately 48-hrs after the live webcast.

      ###

      Press Contact
      Christina Chan
      (732) 524-6297

      Courtney Dugan
      (347) 452-1061

      Investor Contacts:
      Lisa Romanko
      (732) 524-2034

      Jen McIntyre
      (732) 524-3922

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.